These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38941748)

  • 1. Discovery and characterisation of new phage targeting uropathogenic Escherichia coli.
    Asgharzadeh Kangachar S; Logel DY; Trofimova E; Zhu HX; Zaugg J; Schembri MA; Weynberg KD; Jaschke PR
    Virology; 2024 Sep; 597():110148. PubMed ID: 38941748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
    Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
    Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of bacteriophages against E.coli urinary tract infection and evaluating their anti-biofilm activity and antibiotic synergy.
    Devi B A; K V L; Sugumar S
    Microb Pathog; 2024 Aug; 193():106789. PubMed ID: 38972365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
    Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
    mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
    Malik S; Nehra K; Mann A; Jagdish R; Rana JS
    Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
    Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N
    J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
    Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Resistance Among Uropathogenic
    Kot B
    Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel bacteriophage vB_EcoP-EG1 with lytic activity against planktonic and biofilm forms of uropathogenic Escherichia coli.
    Gu Y; Xu Y; Xu J; Yu X; Huang X; Liu G; Liu X
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):315-326. PubMed ID: 30397766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined functional genomic and metabolomic approaches identify new genes required for growth in human urine by multidrug-resistant
    Phan M-D; Schirra HJ; Nhu NTK; Peters KM; Sarkar S; Allsopp LP; Achard MES; Kappler U; Schembri MA
    mBio; 2024 Mar; 15(3):e0338823. PubMed ID: 38353545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
    Zalewska-Piątek BM; Piątek RJ
    Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic
    Salamzade R; McElheny CL; Manson AL; Earl AM; Shaikh N; Doi Y
    mSphere; 2023 Oct; 8(5):e0018423. PubMed ID: 37581436
    [No Abstract]   [Full Text] [Related]  

  • 19. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
    Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
    Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.